Tuberculosis Collection

Empirical treatment of community-acquired pneumonia and the development of fluoroquinolene-resistant tuberculosis

2009

Description

This study aimed to assess outpatient fluoroquinolone (FLQ) use by patients with culture-proven pulmonary TB before diagnosis by linking TB registries in Alberta and Saskatchewan with provincial and federal benefit plans and performing a case-control study to assess FLQ resistance.

Link to Resource

Empirical treatment of community-acquired pneumonia and the development of fluoroquinolene-resistant tuberculosis.

Long, R., Chong, H., Hoeppner, V., Shanmuganathan, H., Kowalewska-Grochowska, K., Shandro, C., Manfreda, J. et al. (2009). Empirical treatment of community-acquired pneumonia and the development of fluoroquinolene-resistant tuberculosis. Clinical Infectious Diseases, 48(10), 1354-60.

Connect with the NCCIH